Skip to Content

Biosyntech Inc BSYI

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BSYI is trading at a 31% discount.
Price
$0.00
Fair Value
$2.46
Uncertainty
Extreme
1-Star Price
$7.30
5-Star Price
$7.21
Economic Moat
Ycwpyq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BSYI is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.01
Market Cap
$114.52
Volume/Avg
550 / 550

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
45

Valuation

Metric
BSYI
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
BSYI
Quick Ratio
0.19
Current Ratio
0.21
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
BSYI
Return on Assets (Normalized)
−184.70%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−262.60%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRWvbcpvwbvPzj$551.2 Bil
VRTX
Vertex Pharmaceuticals IncFqpzdyjGrhtm$101.9 Bil
REGN
Regeneron Pharmaceuticals IncTghdlcdmJjncg$98.1 Bil
MRNA
Moderna IncVlxpwjcLkkm$39.7 Bil
ARGX
argenx SE ADRSzydnjncVvcf$22.1 Bil
BNTX
BioNTech SE ADRBsqxbwmyWxhp$20.8 Bil
ALNY
Alnylam Pharmaceuticals IncRfvzjbwqPrhhwh$18.6 Bil
BMRN
Biomarin Pharmaceutical IncPsdlyymrVgzlszq$17.2 Bil
RPRX
Royalty Pharma PLC Class ADkgchmqwdPkmpfm$12.3 Bil
INCY
Incyte CorpNbywhgrhRjtknn$11.9 Bil

Sponsor Center